Endeavor

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

What Are Bispecifics and How Do They Help Patients With Cancer?

A new class of immunotherapy is giving doctors another way to guide the immune system toward hard to treat cancers

Immunotherapy Pioneer Steven Rosenberg Reflects on Past Breakthroughs and Future Promise

Legendary researcher connects immunotherapy’s origins to its future at Moffitt

What Is Personalized Medicine?

Tailored therapies for individual patients are changing the way cancer is treated

Many Lymphoma Patients Missing Out on Best Care

Study shows survival drops when CAR T therapy is not offered to eligible patients

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions 

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships

Moffitt Cancer Center Leaders Highlight Importance of Cancer Research in D.C.

Ongoing cancer research funding is essential to Moffitt’s mission